Regulatory & Quality Track

Clinical research leaders and teams will gain critical insights and proven best practices to uphold compliance, elevate quality, and ensure excellence in trial execution.

 
Featured
Better (Not) Call FDA: When and How to Flag Regulatory Oversight in Your Study
Apr 27
Better (Not) Call FDA: When and How to Flag Regulatory Oversight in Your Study
Read more →
Beyond the Buzzwords: Oversight, Quality by Design, and Risk-Based Thinking
Apr 27
Beyond the Buzzwords: Oversight, Quality by Design, and Risk-Based Thinking
Read more →
The Ripple Effect: Making ICH E6(R3) Real Across Clinical Research
Apr 27
The Ripple Effect: Making ICH E6(R3) Real Across Clinical Research
Read more →
How Much is Too Much?: Taking a Closer Look at the Ethics of Subject Compensation
Apr 26
How Much is Too Much?: Taking a Closer Look at the Ethics of Subject Compensation
Read more →
Implementation of an IRB Review Level Assessment Tool
Apr 26
Implementation of an IRB Review Level Assessment Tool
Read more →
Communicating Effectively with IRBs for Faster and More Robust Approvals
Apr 26
Communicating Effectively with IRBs for Faster and More Robust Approvals
Read more →
Aligned for Impact: Collaboration for FDA Inspection Readiness in Site Networks
Apr 26
Aligned for Impact: Collaboration for FDA Inspection Readiness in Site Networks
Read more →
Creating Sustainable and Efficient Clinical Research Compliance Programs
Apr 26
Creating Sustainable and Efficient Clinical Research Compliance Programs
Read more →
Behind Closed Doors: The Inner Workings of Institutional Review Boards
Apr 25
Behind Closed Doors: The Inner Workings of Institutional Review Boards
Read more →
2026 U.S Regulatory Update
Apr 25
2026 U.S Regulatory Update
Read more →
Trials in Transition: Navigating HHS Policy Shifts in 2026
Apr 25
Trials in Transition: Navigating HHS Policy Shifts in 2026
Read more →
Starting Quality Assurance and Improvement Programs from the Ground Up
Apr 25
Starting Quality Assurance and Improvement Programs from the Ground Up
Read more →
The ABCs of IDEs: Making Sense of Regulatory Expectations for Investigational Device Exemptions
Apr 25
The ABCs of IDEs: Making Sense of Regulatory Expectations for Investigational Device Exemptions
Read more →
Protecting Vulnerable Patients in Oncology Trials Through Optimized Informed Consent
Apr 25
Protecting Vulnerable Patients in Oncology Trials Through Optimized Informed Consent
Read more →